Jeisys Medical Inc.

KOSDAQ:A287410 Stock Report

Market Cap: ₩960.9b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Jeisys Medical Past Earnings Performance

Past criteria checks 3/6

Jeisys Medical has been growing earnings at an average annual rate of 35.9%, while the Medical Equipment industry saw earnings growing at 16.7% annually. Revenues have been growing at an average rate of 29.1% per year. Jeisys Medical's return on equity is 25.2%, and it has net margins of 16.7%.

Key information

35.9%

Earnings growth rate

32.3%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate29.1%
Return on equity25.2%
Net Margin16.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Jeisys Medical Inc. (KOSDAQ:287410) Looks Just Right With A 31% Price Jump

May 25
Jeisys Medical Inc. (KOSDAQ:287410) Looks Just Right With A 31% Price Jump

Is There An Opportunity With Jeisys Medical Inc.'s (KOSDAQ:287410) 46% Undervaluation?

May 21
Is There An Opportunity With Jeisys Medical Inc.'s (KOSDAQ:287410) 46% Undervaluation?

The Returns On Capital At Jeisys Medical (KOSDAQ:287410) Don't Inspire Confidence

Apr 27
The Returns On Capital At Jeisys Medical (KOSDAQ:287410) Don't Inspire Confidence

Jeisys Medical Inc. (KOSDAQ:287410) Looks Just Right With A 28% Price Jump

Apr 09
Jeisys Medical Inc. (KOSDAQ:287410) Looks Just Right With A 28% Price Jump

Revenue & Expenses Breakdown

How Jeisys Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A287410 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24167,82327,96971,1863,392
31 Mar 24157,88125,04565,2523,049
31 Dec 23143,03024,80055,6712,748
30 Sep 23135,17626,79549,7052,849
30 Jun 23124,71126,05745,2142,663
31 Mar 23120,32027,26042,2812,796
31 Dec 22116,55027,13040,0662,507
30 Sep 22109,14129,21236,9382,726
30 Jun 22100,90428,37933,3482,665
31 Mar 2289,37226,44529,5392,298
31 Dec 2181,29613,86028,2232,193
30 Sep 2169,2476,90725,9461,606
30 Jun 2164,0286,77822,5521,463
31 Mar 2153,426-1,31821,6601,210
31 Dec 2047,8297,15119,4901,134

Quality Earnings: A287410 has a high level of non-cash earnings.

Growing Profit Margin: A287410's current net profit margins (16.7%) are lower than last year (20.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A287410's earnings have grown significantly by 35.9% per year over the past 5 years.

Accelerating Growth: A287410's earnings growth over the past year (7.3%) is below its 5-year average (35.9% per year).

Earnings vs Industry: A287410 earnings growth over the past year (7.3%) exceeded the Medical Equipment industry 4%.


Return on Equity

High ROE: A287410's Return on Equity (25.2%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/11/08 11:33
End of Day Share Price 2024/10/18 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jeisys Medical Inc. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sae-rom LeeDaishin Securities Co. Ltd.
Jonghyun ParkDAOL Investment & Securities Co., Ltd.
Sangsoo KimGoldman Sachs